Mosaic ImmunoEngineering, Inc. (CPMV)

OTCMKTS · Delayed Price · Currency is USD
0.5000
-0.0630 (-11.19%)
Mar 18, 2026, 3:50 PM EST
Market Cap3.62M -9.1%
Revenue (ttm)n/a
Net Income-671.75K
EPS-0.10
Shares Out7.24M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,600
Average Volume1,017
Open0.5000
Previous Close0.5630
Day's Range0.5000 - 0.5000
52-Week Range0.2520 - 1.0500
Beta-0.78
RSI49.33
Earnings DateFeb 27, 2026

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. It engages in pursuing new product candidates and platforms to build a new pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Employees 8
Stock Exchange OTCMKTS
Ticker Symbol CPMV
Full Company Profile

Financial Performance

Financial Statements